Insights

Innovative Technology Platforms Celyad Oncology is leveraging proprietary CAR T-cell technology platforms, indicating potential demand for advanced bioprocessing equipment, laboratory automation tools, and specialized analytical technologies to support their clinical and manufacturing development efforts.

Executive Leadership Changes Recent appointments of new CEOs suggest ongoing strategic shifts which may open opportunities for consulting, executive education, or leadership development services tailored to biopharmaceutical innovation and corporate restructuring.

Funding and Growth With recent private placements of nearly EUR 10 million and other financing activities, Celyad Oncology may require partner solutions in funding management, financial planning, or investor relations services to optimize their capital deployment.

Clinical Development Focus Their ongoing evaluation of shRNA technology and clinical trials such as IMMUNICY-1 presents a chance to provide clinical research services, regulatory consulting, or advanced laboratory testing solutions for cutting-edge gene editing therapies.

Market Positioning Operating in a competitive landscape with companies like Allogene and CRISPR Therapeutics, Celyad’s focus on next-generation CAR T-cell therapies highlights opportunities to offer partnership-driven solutions in licensing, joint development, or technology scaling to accelerate their R&D pipeline.

Celyad Oncology Tech Stack

Celyad Oncology uses 8 technology products and services including SAP, JSON-LD, Lodash, and more. Explore Celyad Oncology's tech stack below.

  • SAP
    Customer Relationship Management
  • JSON-LD
    Javascript Frameworks
  • Lodash
    Javascript Libraries
  • jQuery
    Javascript Libraries
  • PHP
    Programming Languages
  • Contact Form 7
    Web Platform Extensions
  • Apache
    Web Servers
  • bxSlider
    Web Tools And Plugins

Media & News

Celyad Oncology's Email Address Formats

Celyad Oncology uses at least 1 format(s):
Celyad Oncology Email FormatsExamplePercentage
FLast@celyad.comJDoe@celyad.com
87%
FMiddleLast@celyad.comJMichaelDoe@celyad.com
5%
FirstLast@celyad.comJohnDoe@celyad.com
4%
FiLast@celyad.comJoDoe@celyad.com
4%

Frequently Asked Questions

Where is Celyad Oncology's headquarters located?

Minus sign iconPlus sign icon
Celyad Oncology's main headquarters is located at 9 rue André Dumont, Mont-Saint-Guibert, 1435, BE. The company has employees across 2 continents, including EuropeNorth America.

What is Celyad Oncology's phone number?

Minus sign iconPlus sign icon
You can contact Celyad Oncology's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Celyad Oncology's stock symbol?

Minus sign iconPlus sign icon
Celyad Oncology is a publicly traded company; the company's stock symbol is CYAD.

What is Celyad Oncology's official website and social media links?

Minus sign iconPlus sign icon
Celyad Oncology's official website is celyad.com and has social profiles on LinkedIn.

What is Celyad Oncology's SIC code NAICS code?

Minus sign iconPlus sign icon
Celyad Oncology's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Celyad Oncology have currently?

Minus sign iconPlus sign icon
As of October 2025, Celyad Oncology has approximately 24 employees across 2 continents, including EuropeNorth America. Key team members include Chief Executive Officer: M. K.Head Of Research And Development: E. B.Head Of Ip / European Patent Attorney: H. I.. Explore Celyad Oncology's employee directory with LeadIQ.

What industry does Celyad Oncology belong to?

Minus sign iconPlus sign icon
Celyad Oncology operates in the Biotechnology Research industry.

What technology does Celyad Oncology use?

Minus sign iconPlus sign icon
Celyad Oncology's tech stack includes SAPJSON-LDLodashjQueryPHPContact Form 7ApachebxSlider.

What is Celyad Oncology's email format?

Minus sign iconPlus sign icon
Celyad Oncology's email format typically follows the pattern of FLast@celyad.com. Find more Celyad Oncology email formats with LeadIQ.

When was Celyad Oncology founded?

Minus sign iconPlus sign icon
Celyad Oncology was founded in 2007.
Celyad Oncology

Celyad Oncology

Biotechnology ResearchBelgium11-50 Employees

Celyad Oncology is a cutting-edge biotechnology company dedicated to pioneering the discovery and advancement of revolutionary technologies for chimeric antigen receptor (CAR) T-cells. Its primary objective is to unlock the potential of its proprietary technology platforms and intellectual property, enabling to be at the forefront of developing next-generation CAR T-cell therapies. By fully leveraging its innovative technology platforms, Celyad Oncology aims to maximize the transformative impact of its candidate CAR T-cell therapies and redefine the future of CAR T-cell treatments. Celyad Oncology is based in Mont-Saint-Guibert, Belgium. For more information, please visit www.celyad.com.

Section iconCompany Overview

Headquarters
9 rue André Dumont, Mont-Saint-Guibert, 1435, BE
Phone number
Website
celyad.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
CYAD
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2007
Employees
11-50

Section iconFunding & Financials

  • $1M$10M

    Celyad Oncology's revenue is estimated to be in the range of $1M$10M

Section iconFunding & Financials

  • $1M$10M

    Celyad Oncology's revenue is estimated to be in the range of $1M$10M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.